Teikoku Pharma granted FDA Fast Track designation for TPU-006, a novel 4-day dexmedetomidine transdermal system for postoperative pain management. News release. June 21, 2023.

Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain [Abstract]. https://pubmed.ncbi.nlm.nih.gov/15563741/ Lidocaine 5% patch for ...

A study published in Medical Cannabis and Cannabinoids examined the treatment of diabetic peripheral neuropathy (DPN) using medical cannabis transdermal patches. DPN is a neurological disorder caused ...

Transdermal lidocaine 5% patch should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures between 59 F to 86 F (15 C to 30 C) for shorter periods ...

Overview: Transdermal estradiol is available as a patch, gel, or spray that is applied to the skin to increase estrogen levels. It is used after menopause to prevent osteoporosis or to reduce ...

Innovations in microneedle and smart patch technologies are boosting efficacy and compliance, while government healthcare initiatives enhance access. Major players include Teva Pharmaceutical, 3M, and ...